Patents by Inventor Joachim Goring

Joachim Goring has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4784999
    Abstract: A method for the treatment of cerebral vascular and neuronal degenerative disorders associated with learning, memory and cognitive dysfunctions including cerebral senility, multi-infarct dementia and senile dementia of the Alzheimer type and/or peripheral vascular disease and/or proliferative skin disease in mammals, such as humans, which comprises administering to the mammal in need of such treatment an effective amount of 1,3-di-n-butyl-7-(2-oxypropyl) xanthine or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: September 11, 1987
    Date of Patent: November 15, 1988
    Assignee: Beecham Wuelfing GmbH & Co. KG
    Inventors: Dieter Angersbach, Charles D. Nicholson, Joachim Goring, Brian Morgan, Jonathan R. S. Arch
  • Patent number: 4291037
    Abstract: 7-(Oxoalkyl)-1,3-dialkyl xanthines whose substituents in the 1- and 3-positions are alkyl groups of 2 to 6 carbons, cyclohexyl, alkoxyalkyl or hydroxyalkyl, such as 7-(3-oxobutyl)-1,3-di-n-butylxanthine, are effective vasodilators, having a marked activity in promoting blood flow through skeletal muscle, while at the same time exhibiting low toxicity.
    Type: Grant
    Filed: June 4, 1979
    Date of Patent: September 22, 1981
    Assignee: Johann A. Wulfing
    Inventors: Gunther Brenner, Joachim Goring, Eskendar Ali Khan, Oskar Rohte, Manfred Tauscher
  • Patent number: 4242345
    Abstract: 7-(Oxoalkyl)-1,3-dialkyl xanthines whose substituents in the 1- and 3-positions are alkyl groups of 2 to 6 carbons, cyclohexyl, alkoxyalkyl or hydroxyalkyl, such as 7-(3-oxobutyl)-1,3-di-n-butylxanthine, are effective vasodilators, having a marked activity in promoting blood flow through skeletal muscle, while at the same time exhibiting low toxicity.
    Type: Grant
    Filed: September 19, 1978
    Date of Patent: December 30, 1980
    Assignee: Johann A. Wulfing
    Inventors: Gunther Brenner, Joachim Goring, Eskendar Ali Khan, Oskar Rohte, Manfred Tauscher
  • Patent number: 4092417
    Abstract: The salts of N-unsubstituted, N-monosubstituted and N,N-disubstituted 7-(3-amino-2-hydroxypropyl)theophylline and 5-methylisoxazole-3-carboxylic acid are hypolipidaemic agents. The compounds, of which the 7-[3-(N-methyl-N-2-hydroxyethyl)amino-2-hydroxypropyl]-theophylline salt of 5-methylisoxazole-3-carboxylic acid is a representative embodiment, are prepared by allowing the isoxazole acid and the amine to react.
    Type: Grant
    Filed: December 8, 1976
    Date of Patent: May 30, 1978
    Assignee: Johann A. Wulfing
    Inventors: Karl Credner, Joachim Goring, Gunter Brenner, Manfred Tauscher
  • Patent number: 3980646
    Abstract: This invention relates to 3-methylpyrazole-5-carboxylates, to processes for the preparation of said compounds and to pharmaceutical compositions containing said compounds.
    Type: Grant
    Filed: August 1, 1975
    Date of Patent: September 14, 1976
    Assignee: Johann A. Wulfing
    Inventors: Gunter Brenner, Karl Credner, Joachim Goring, Manfred Tauscher
  • Patent number: 3946013
    Abstract: 1,3-BIS(.beta.-ETHYLHEXYL)-5-AMINO-5-METHYLHEXAHYDROPYRIMIDINE PYRIDINE-3-CARBOXYLATE(HEXETIDINE NICOTINATE), WHICH HAS GREATER BACTERIOSTATIC ACTIVITY AND LOWER TOXICITY IN COMPARISON WITH HEXETIDINE OR OTHER SALTS OF HEXETIDINE, IS PREPARED BY REACTING HEXETIDINE OR AN ACID ADDITION SALT THEREOF WITH NICOTINIC ACID IN AN ORGANIC SOLVENT.
    Type: Grant
    Filed: February 28, 1974
    Date of Patent: March 23, 1976
    Assignee: Johann A. Wulfing
    Inventors: Manfred Tauscher, Joachim Goring, Wolfgang Busch, Oskar Rohte